Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | SRC | P12931 | 2/20 | 0.35 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.35 |
| ▸ | METTL3 | Q86U44 | 1/20 | 0.35 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.35 |
| ▸ | ABL1 | P00519 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | ABL2 | P42684 | 1/20 | 0.35 |
| ▸ | STS | P08842 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CCRL2 | O00421 | 1/20 | 0.34 |
| ▸ | DNMT3A | Q9Y6K1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24314225 | 1.00 | ADORA3 (0.38) | ADORA3EPHX2MAPTSRCPRMT5 | |
| SCHEMBL24313535 | 0.91 | ADORA3 (0.40) | ADORA3PRMT5METTL3WDR77 | |
| SCHEMBL29610818 | 0.91 | ADORA3 (0.40) | ADORA3PRMT5METTL3WDR77 | |
| SCHEMBL29611495 | 0.90 | METTL3 (0.47) | PRMT5METTL3WDR77 | |
| SCHEMBL24314226 | 0.90 | METTL3 (0.47) | PRMT5METTL3WDR77 | |
| SCHEMBL24313565 | 0.84 | ADORA3 (0.43) | ADORA3MAPTALDH1A1 | |
| SCHEMBL29610857 | 0.84 | ADORA3 (0.43) | ADORA3MAPTALDH1A1 | |
| SCHEMBL24313864 | 0.84 | ADORA3 (0.43) | ADORA3MAPTALDH1A1 | |
| SCHEMBL29611653 | 0.84 | ADORA3 (0.43) | ADORA3MAPTALDH1A1 | |
| SCHEMBL30642217 | 0.83 | PRMT5 (0.45) | PRMT5METTL3WDR77 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4229067-A1 | METTL3 MODULATORS | Accent Therapeutics, Inc. (US) | 2023-08-23 | — | — | EP | disclosed |
| WO-2022081739-A1 | METTL3 MODULATORS | ACCENT THERAPEUTICS, INC. (US) | 2022-04-21 | — | — | WO | disclosed |